A Win for Small–Cell Lung Cancer: IMPOWER 133

preview_player
Показать описание
An expert panel comments on the positive results of the IMpower 133 trials, which evaluated the use of carboplatin, etoposide, and atezolizumab in extensive-stage small–cell lung cancer.
Рекомендации по теме
join shbcf.ru